Career Development Special Event
A Panel Discussion Moderated by:
Anne-Maree Cantwell, MD, MBA, Venture Partner, Empactful Capital LLC; CEO and Founder, Digital Healthcare Advisors; Board Member, Mill Valley Library Foundation; and Advisory Board Member, WatchTAG
Research has shown that having gender-diverse boards is positively correlated with better financial and non-financial performance, contributing to overall company growth and Environmental, Social, and Governance (“ESG”) performance. Join us for this special event to hear from three highly successful Wharton women executives who have served on a variety of types of healthcare boards and learn from their experience as company directors. Topics to be addressed include, but will not be limited to:
Our Organizer and Moderator:
Anne-Maree Cantwell, MD, MBA
Our Esteemed Panelists:
Stacey Seltzer is a Partner with Gurnet Point Capital (GPC) which she joined in 2022. Prior to joining GPC, Stacey was a Partner at Aisling Capital where she invested in life sciences companies. Over the course of her 14 years at Aisling, Stacey’s board service included Agile Therapeutics, Aimmune Therapeutics (acquired by Nestle Health), AVROBIO, Durata Therapeutics (acquired by Actavis), Miramar Labs (acquired by Sientra), Promentis Pharmaceuticals, Prolacta Bioscience, Spruce Biosciences, and ZELTIQ Aesthetics (acquired by Allergan). Stacey currently serves as a director of Reneo Pharmaceuticals.
Maureen Spivack serves as Non-Executive Chairwoman of the Board of Excelin Health, a Home Health and Hospice Services provider, and a Corinthian portfolio company. She joined the company’s board in 2018 and was named chairwoman in 2022.
As executive advisor to Corinthian Capital, she provides valuable insight and expertise for sourcing opportunities and evaluating acquisitions in the healthcare industry. Maureen also served as the past Chairperson of the Board of Community Health Accreditation Partner (CHAP), the national accreditation body for community-based healthcare.
Barbara Troupin is a serial Chief Medical Officer, startup/C-suite/VC advisor, and public-company independent board director. She currently sits on the Board and is a member of the Nomination and Governance Committee for Equillium Bio (NASDAQ:EQ). Over her 20+ years as a life science executive, her roles have spanned Clinical, Medical, Regulatory, Operations and Strategy functional areas, and she has worked at both private and public companies. Barbara is a member of Athena Alliance, a group that promotes board service among women, and where she runs a monthly peer group of Women in Life Sciences.
Fees and Registration:
- Participation is free to Dues Paying Members of the WHCMAA and Current WHCM Program Students Only.
- Others are welcome to participate for a $25 fee.
Purchase Ticket below
Zoom access info will be provided in confirmation email upon registration
If you need assistance with your registration, please contact our club administrator at [email protected].